Lyra Therapeutics Financial Overview
Lyra Therapeutics's market cap is currently $6.45M. The company's EPS TTM is $-3.38; its P/E ratio is ―; Lyra Therapeutics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-1.92. See an overview of income statement, balance sheet, and cash flow financials.
